Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis

European Neurology

Volumn 67, Issue 1, 2012, Pages 52-56

  Šaňák, Daniel ^a   Kuliha, Martin ^b   Herzig, Roman ^a   Roubec, Martin ^b   Školoudík, David ^a,b   Zapletalová, Jana ^a   Köcher, Martin ^a   Král, Michal ^a   Veverka, Tomáš ^a   Čecháková, Eva ^a   Bártková, Andrea ^a   Procházka, Václav ^c   Kaňovský, Petr ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Department of Neurology   (Czech Republic)

^c UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Antiplatelet therapy; Intravenous thrombolysis; Ischemic stroke; Middle cerebral artery occlusion; Recanalization

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; DIPYRIDAMOLE; GLUCOSE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECANALIZATION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

AGED; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 83155168281     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000333064     Document Type: Article

References (23)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
2. Update Guidelines January 2009 New Elements. http://www.eso-stroke.org/ pdf/ESO-Extended-Thrombolysis-KSU.pdf.
3. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-2902.
4. Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV: Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89-93.
5. Labiche LA, Malkoff M, Alexandrov AV: Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging 2003;13:28-33.
6. Ribo M, Alvarez-Sabin J, Montaner J, Romero F, Delgado P, Rubiera M, Delgado-Mederos R, Molina CA: Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006;37:1000-1004.
7. Wolpert S, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993;14:3-13.
8. Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a metaanalysis. Stroke 2007;38:967-973.
9. Zangerle A, Kiechl S, Spiegel M, Furtner M, Knoflach M, Werner P, Mair A, Wille G, Schmidauer C, Gautsch K, Gotwald T, Felber S, Poewe W, Willeit J: Recanalization after thrombolysis in stroke patients. Predictors and prognostic implications. Neurology 2007;68:39-44.
10. Askevold ET, Naess H, Thomassen L: Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis 2007;16:21-24.
11. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, Lyden PD: Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32:661-668.
12. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ: Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Arch Neurol 2008;65:607-611.
13. Ibrahim MM, Sebastian J, Hussain M, Al-Hussain F, Uchino K, Molina C, Khan K, Demchuk AM, Alexandrov AV, Saqqur M, CLOTBUST Investigators: Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogenactivator-mediated recanalization rate in patients with acute ischemic stroke? Cerebrovasc Dis 2010;30:508-513.
14. Hacke W, Kaste M, Bogousslavsky J, Braunin M, Gugging M, Chamorro A, Lees K, Leys D, Kwiecinski H, Toni D: European stroke initiative recommendations for stroke management - update 2003. Cerebrovasc Dis 2003;16:311-337.
15. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee: Guidelines for management of ischemic stroke and transient ischemic attack 2008. Cerebrovasc Dis 2008;25:457-507.
16. Higashida RT, Furlan A: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:109-137.
17. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, SITS-MOST investigators: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282.
18. Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB: Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial. Cerebrovasc Dis 2010;29:79-81.
19. Adams HP, Effron MB, Torner J, Dávalos A, Frayne J, Teal P, Leclerc J, Pekar B, Padgett L, Barnathan ES, Hacke W, AbESTT-II Investigators: Emergency administration of Abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial. Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99.
20. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hill MD, Alexandrov AV, CLOTBUST Investigators: Association of pretreatment blood pressure with tissue plasminogen activatorinduced arterial recanalization in acute ischemic stroke. Stroke 2007;38:961-966.
21. Ovbiagele B, Saver JL: The smoking-thrombolysis paradox and acute ischemic stroke. Neurology 2005;26:293-295
22. Hacke W, Donnan G, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
23. Nedelmann M, Stolz E, Gerriets T, Baumgartner RW, Malferrari G, Seidel G, Kaps M, TCCS Consensus Group: Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke 2009;40:3238-3244.